Related Experiment Video
Updated: Sep 26, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356
Yasuhiro Igarashi1, Katsuyuki Futamata, Tsuyoshi Fujita
1Biotechnology Research Center, Toyama Prefectural University, 5180, Kurokawa, Kosugi, Toyama 939-0398, Japan. yas@pu-toyama.ac.jp
Abstract:
In the screening of novel antifungal compounds, yatakemycin was found in the culture broth of Streptomyces sp. TP-A0356. Yatakemycin was obtained by solvent extraction of the fermentation broth and chromatographic purification using ODS column and preparative HPLC. The structure of yatakemycin was elucidated by NMR and CID-MS/MS experiments as a novel antibiotic belonging to a family of CC-1065 and duocarmycins known to be DNA alkylating agents. Yatakemycin inhibited the growth of pathogenic fungi such as Aspergillus fumigatus and Candida albicans with the MIC values of 0.01-0.03 microg/ml, more potent than amphotericin B (MIC: 0.1-0.5 microg/ml) or itraconazole (MIC: 0.03-0.2 microg/ml). It also showed potent cytotoxicity against cancer cell lines with the IC50 of 0.01-0.3 microg/ml.
Related Concept Videos
Antifungal Agents
Production of Antibiotics
Inhibitors of Bacterial Protein Synthesis
Anthelminthic Agents
Clinical Significance of Antibiotic Resistance
Drugs that Destabilize Microtubules

